SCHEMBL22003249

SCHEMBL22003249

CC(C)SC1C[C@H]2CC(C(C)C)[C@@H]1C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20622919 1.00 — —
SCHEMBL20622918 0.77 — —
SCHEMBL3901374 0.67 TRPA1 (0.40) —
SCHEMBL11131465 0.62 SLC22A2 (0.33) —
SCHEMBL3911741 0.62 — —
SCHEMBL21475420 0.59 — —
SCHEMBL18467477 0.55 — —
SCHEMBL17930574 0.55 — —
SCHEMBL3913118 0.54 HSD11B1 (0.33) —
SCHEMBL24612981 0.53 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11229709-B2 Dendrimer drug conjugates for sustained intra-articular delivery MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2022-01-25 — — US disclosed
US-20200155692-A1 DENDRIMER DRUG CONJUGATES FOR SUSTAINED INTRA-ARTICULAR DELIVERY UNITED STATES GOVERNMENT 2020-05-21 — — US disclosed
Send feedback